Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Boehringer Ingelheim
Harvard Business School
UBS
Merck
Fuji
Chinese Patent Office
Novartis
McKinsey
Johnson and Johnson

Generated: October 20, 2017

DrugPatentWatch Database Preview

Drug Master Files for: cobalt

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
109I5/28/1953LLOYD BROS INCCOBALT
151I6/1/1955LLOYD BROS INCCOBALT
1577III10/8/1970EI DUPONT DE NEMOURS AND CO INCCOBALT-57
6554AV8/18/1986SYNERGY HEALTH STERILISATION UK LTDCOBALT 60 GAMMA IRRADIATION CONTRACT STERILIZATION FACILITY LOCATED IN READING, BERKSHIRE, ENGLAND
6555AV8/18/1986SYNERGY HEALTH STERILISATION UK LTDCOBALT 60 GAMMA IRRADIATION CONTRACT STERILIZATION FACILITY LOCATED IN BRADFORD, WEST YORKSHIRE, ENGLAND
10255AV5/18/1993SYNERGY HEALTH WESTPORT LTDCOBALT 60 GAMMA IRRADIATION CONTRACT STERILIZATION FACILITY LOCATED IN WESTPORT, CO. MAYO, IRELAND.
19826IIII6/6/2006T AND S BLOWMOULDING INCCOBALT 60 GAMMA IRRADIATION CONTRACT STERILIZATION FACILITY LOCATED IN READING, BERKSHIRE, ENGLAND
19827IIII6/6/2006T AND S BLOWMOULDING INCCOBALT 60 GAMMA IRRADIATION CONTRACT STERILIZATION FACILITY LOCATED IN BRADFORD, WEST YORKSHIRE, ENGLAND
27318AIII7/11/2013LEVOSIL SPA100% COBALT FREE HUMIDITY INDICATOR CARDS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Cerilliant
Novartis
Covington
Deloitte
Harvard Business School
QuintilesIMS
Federal Trade Commission
Fuji
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot